株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の体外診断(IVD)市場:予測・企業分析

China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis

発行 Renub Research 商品コード 320308
出版日 ページ情報 英文 77 Pages; 34 Figures
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
中国の体外診断(IVD)市場:予測・企業分析 China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
出版日: 2014年12月02日 ページ情報: 英文 77 Pages; 34 Figures
概要

中国の体外診断(IVD)市場規模は、2018年までに金額ベースで2013年の市場規模の2倍以上に拡大すると予測されています。セグメント別では、免疫測定市場は最大の市場シェアを構成しています。臨床化学は第2位につけており、市場シェアは年々減少しているものの、市場は年々拡大しています。分子診断は第3位の位置に付けており、市場シェアは年々拡大しています。企業別ではRocheが最大の市場シェアを構成しています。

当レポートでは、中国の体外診断(IVD)市場について調査し、市場規模と予測、セグメント別の市場と予測、発展環境と規制状況、および企業別のIVD売上・予測などをまとめ、お届けいたします。

第1章 エグゼクティブサマリー

第2章 中国のIVD市場・市場シェア

  • 中国のIVD市場
  • 中国のIVD市場シェア
  • 中国のIVD市場企業のシェア

第3章 中国のIVD市場:セグメント別

  • 中国の臨床化学市場
  • 中国の免疫測定法市場
  • 中国の血液学市場
  • 中国の凝固市場
  • 中国の微生物学市場
  • 中国の分子検査市場
  • 中国の血糖セルフモニタリング(SMBG)市場
  • 中国のポイントオブケア(POCT)市場

第4章 中国のIVD産業の発展環境

  • 医療改革の状況
  • 国民利益政策の状況
  • 病院アップグレードの要件

第5章 体外診断試薬登録管理のプロファイル

  • 中国のIVD市場における規制の歴史
  • 中国のIVD市場における規制状況
  • 中国のIVD市場における規制動向

第6章 中国のIVD産業促進因子

  • ラボ検査を規制するための政府の取り組み
  • 民間の病院・独立検査ラボ数の増加

第7章 中国のIVD産業における課題

  • ローカル企業における先進技術専門知識の不足
  • 中国のIVD市場において価格圧力が多国籍IVD企業の参加を抑制
  • 各製品の医療費償還率は各地域によってさまざま

第8章 中国のIVD市場:企業別の売上分析

  • Roche Diagnostic:中国のIVD売上・予測
  • Sysmex Corporation:中国のIVD売上・予測
  • Mindray Medical International Limited:中国のIVD売上・予測
  • Shanghai Kehua Bio-Engineering Co. Ltd.:中国のIVD売上・予測
  • その他:中国のIVD売上・予測

第9章 主な民間臨床ラボおよび診断サービス企業のプロファイル

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 企業概要
    • 提供製品・サービス
  • ADICON Clinical Laboratories (Privately held)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen
  • OriGene Technologies

図表リスト

目次

China is gradually becoming a competitive force and evolving into the world's fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.

This is 3rd edition report on In Vitro Diagnostics sector by Renub Research . Report titled "China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis " provides a comprehensive assessment of the fast-evolving, high-growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points :

  • 1) Market and Forecast
  • 2) Segment Wise Market & Forecast
  • 3) Development Environment & Regulatory Status in China IVD market
  • 4) Company Wise IVD Sales & Forecast

China IVD Market - Application Segment Analysis (2007 - 2018)

  • Clinical Chemistry Market
  • Immunoassay Market
  • Hematology Market
  • Coagulation Market
  • Microbiology Market
  • Molecular Testing Market
  • Self Monitoring of Blood Glucose (SMBG) Market
  • Point of Care Testing (POCT) Market

China IVD - Company Wise Sales Analysis (2010 - 2018)

  • Roche Diagnostic
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Shanghai Kehua Bio-Engineering Co. Ltd.
  • Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (Privately held)
  • BGI-Shenzhen (Privately held)
  • OriGene Technologies (Privately held)

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. China IVD Market & Market Share (2007 - 2018)

  • 2.1 China IVD Market (2007 - 2018)
  • 2.2 China IVD Market Share (2007 - 2018)
  • 2.3 China IVD Market Players Share (2010 - 2018)

3. China IVD Market by Segments (2007 - 2018)

  • 3.1 China Clinical Chemistry Market (2007 - 2018)
  • 3.2 China Immunoassay Market (2007 - 2018)
  • 3.3 China Hematology Market (2007 - 2018)
  • 3.4 China Coagulation Market (2007 - 2018)
  • 3.5 China Microbiology Market (2007 - 2018)
  • 3.6 China Molecular Testing Market (2007 - 2018)
  • 3.7 China Self Monitoring of Blood Glucose (SMBG) Market (2007 - 2018)
  • 3.8 China Point of Care Testing (POCT) Market (2007 - 2018)

4. Development Environment of Chinese IVD Industry

  • 4.1 State Healthcare Reforms
  • 4.2 State Citizen-Benefiting Policies
  • 4.3 Requirements of Hospital Upgrading

5. Profile of In-vitro Diagnostic Reagents Registration Control

  • 5.1 Regulatory History in China IVD Market
  • 5.2 Regulatory Status in China IVD Market
    • 5.2.1 Blood Screening Reagents - Drug Administration
    • 5.2.2 Varieties of Blood Screening Reagents
    • 5.2.3 Blood Screening Reagent Test
    • 5.2.4 Nucleic Acid Detection Kits for Blood Screening
    • 5.2.5 Radioactive reagents - Drug Administration
    • 5.2.6 Diagnostic Reagents - Medical Devices Management
  • 5.3 Regulatory Trend in China IVD Market
    • 5.3.1 Blood Screening Reagents Belonging
    • 5.3.2 Quality Improvement
    • 5.3.3 Pre-Evaluation of Registration Standards

6. China IVD Industry Drivers

  • 6.1 Government Efforts to Regulate Laboratory testing
  • 6.2 Increasing Number of Private Hospitals & Independent Testing Laboratories

7. China IVD Industry Challenge

  • 7.1 Lack of Expertise in Advanced Technology in the Local Companies
  • 7.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
  • 7.3 Reimbursement Rates of Different Products are Various in Different Provinces

8. China IVD Market - Company Wise Sales Analysis (2010 - 2018)

  • 8.1 Roche Diagnostic - China IVD Sales & Forecast (2010 - 2018)
  • 8.2 Sysmex Corporation - China IVD Sales & Forecast (2010 - 2018)
  • 8.3 Mindray Medical International Limited - China IVD Sales & Forecast (2010 - 2018)
  • 8.4 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast (2010 - 2018)
  • 8.5 Others - China IVD Sales & Forecast (2010 - 2018)

9. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 9.1 Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Products and Services Offered by Di'an
  • 9.2 ADICON Clinical Laboratories (Privately held)
    • 9.2.1 Company Overview
    • 9.2.2 Products and Services Offered by ADICON
  • 9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Products and Services Offered by Kingmed
  • 9.4 Kindstar Global (Privately held)
    • 9.4.1 Company Overview
    • 9.4.2 Products and Services Offered by Kindstar
  • 9.5 BGI-Shenzhen
    • 9.5.1 Company Overview
    • 9.5.2 BGI's Innovative Approach
  • 9.6 OriGene Technologies
    • 9.6.1 Company Overview
    • 9.6.2 Products and Services Offered by OriGene

List of Figure:

  • Figure 2-1: China - IVD Market (Million US$), 2007 - 2013
  • Figure 2-2: China - Forecast for IVD Market (Million US$), 2014 - 2018
  • Figure 2-3: China - IVD Market Share (Percent), 2007 - 2013
  • Figure 2-4: China - Forecast for IVD Market Share (Percent), 2014 - 2018
  • Figure 2-5: China - IVD Market Players Share (Percent), 2010 - 2013
  • Figure 2-6: China - Forecast for IVD Market Players Share (Percent), 2014 - 2018
  • Figure 3-1: China - Clinical Chemistry Market (Million US$), 2007 - 2013
  • Figure 3-2: China - Forecast for Clinical Chemistry Market (Million US$), 2014 - 2018
  • Figure 3-3: China - Immunoassay Market (Million US$), 2007 - 2013
  • Figure 3-4: China - Forecast for Immunoassay Market (Million US$), 2014 - 2018
  • Figure 3-5: China - Hematology Market (Million US$), 2007 - 2013
  • Figure 3-6: China - Forecast for Hematology Market (Million US$), 2014 - 2018
  • Figure 3-7: China - Coagulation Market (Million US$), 2007 - 2013
  • Figure 3-8: China - Forecast for Coagulation Market (Million US$), 2014 - 2018
  • Figure 3-9: China - Microbiology Market (Million US$), 2007 - 2013
  • Figure 3-10: China - Forecast for Microbiology Market (Million US$), 2014 - 2018
  • Figure 3-11: China - Molecular Testing Market (Million US$), 2007 - 2013
  • Figure 3-12: China - Forecast for Molecular Testing Market (Million US$), 2014 - 2018
  • Figure 3-13: China - SMBG Market (Million US$), 2007 - 2013
  • Figure 3-14: China - Forecast for SMBG Market (Million US$), 2014 - 2018
  • Figure 3-15: China - POCT Market (Million US$), 2007 - 2013
  • Figure 3-16: China - Forecast for POCT Market (Million US$), 2014 - 2018
  • Figure 6-1: China - Healthcare Spending (Billion US$), 2011 & 2020
  • Figure 8-1: Roche Diagnostic - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-2: Roche Diagnostic - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-3: Sysmex Corporation - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-4: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-5: Mindray Medical - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-6: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-7: Shanghai Kehua - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-8: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 8-9: Others - China IVD Revenue (Million US$), 2010-2013
  • Figure 8-10: Others - Forecast for China IVD Revenue (Million US$), 2014-2018
  • Figure 9-1: Kindstar - Collaboration with Hospitals in China (Number), 2006-2012
Back to Top